Activation of dendritic cells by microparticles containing Bacillus anthracis protective antigen

Vaccine

Volumn 23, Issue 29, 2005, Pages 3857-3863

  Westwood, Angie ^a   Healey, Gareth D ^a   Williamson, E Diane ^a   Eyles, Jim E ^a  

^a Biomedical Sciences   (United Kingdom)

Author keywords

Anthrax; Antigen presentation; Dendritic cells; Microspheres; Vaccine

Indexed keywords

B7 ANTIGEN; BACTERIAL ANTIGEN; CD86 ANTIGEN; DIPALMITOYLPHOSPHATIDYLCHOLINE; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; POLYLACTIDE; POLYVINYL ALCOHOL; RECOMBINANT PROTEIN; THYMIDINE; TRITIUM;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; BACILLUS ANTHRACIS; BONE MARROW; CELL ACTIVATION; CELL PROLIFERATION; COCULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOGENICITY; IN VITRO STUDY; MICROENCAPSULATION; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL;

ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; BACTERIAL TOXINS; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; INTERCELLULAR ADHESION MOLECULE-1; MEMBRANE GLYCOPROTEINS; MICE; MICROSPHERES; SPLEEN;

EID: 18944376588     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.11.079     Document Type: Article

References (22)

1. J. Keppie, H. Smith, and P.W. Harris-Smith The chemical basis of the virulence of Bacillus anthracis. III. The role of the terminal bacteraemia in death of guinea pigs from anthrax Br J Exp Pathol 36 1955 315 322
2. H. Smith, J. Keppie, and J.L. Stanley The chemical basis of the virulence of Bacillus anthracis. V. The specific toxin produced by B. anthracis in vivo Br J Exp Pathol 36 1955 460 472
3. G.P. Gladstone Immunity to anthrax. Protective antigen present in cell-free culture filtrates Br J Exp Pathol 27 1946 349 418
4. P.C.B. Turnbull Anthrax vaccines: past, present and future Vaccine 9 1991 533 539
5. B.E. Ivins, and S.L. Welkos Recent advances in the development of an improved human anthrax vaccine Eur J Epidimiol 4 1988 12 19
6. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245 252
7. C.A. Janeway The immune system evolved to discriminate infectious non-self from non-infectious self Immunol Today 13 1 1992 11 16
8. P. Guermonprez, J. Valladeau, L. Zitvogel, C. Théry, and S. Amigorena Antigen presentation and T-cell stimulation by dendritic cells Ann Rev Immunol 20 2002 621 667
9. F. Sallusto, and A. Lanzavecchia Understanding dendritic cell and T-lymphocyte traffic through analysis of chemokine receptor expression Immunol Rev 177 2000 134 140
10. L. Flores-Romo In vivo maturation and migration of dendritic cells Immunology 102 2001 255 262
11. J.E. Eyles, I.D. Spiers, E.D. Williamson, and H.O. Alpar Analysis of local and systemic immunological responses after intra-tracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines Vaccine 16 20 1998 2000 2009
12. I. Gutierro, R.M. Hernandez, M. Igartua, A.R. Gascon, and J.L. Pedraz Influence of dose and immunization route on the serum IgG antibody response to BSA-loaded PLGA microspheres Vaccine 20 17/18 2002 2181 2190
13. J. Miller, B.W. McBride, R.J. Manchee, P. Moore, and L.W.J. Baillie Production and purification of recombinant protective antigen and protective efficacy against Bacillus anthracis Lett Appl Microbiol 26 1 1998 56 60
14. L.R. Beck, D.R. Cowsar, D.H. Lewis, R.J. Cosgrove Jr., C.T. Riddle, and S.L. Lowry A new long-acting microcapsule system for the administration of progesterone Fertil Steril 31 5 1979 545 551
15. I.D. Spiers, H.O. Alpar, J.E. Eyles, A. Bozkir, J. Miller, and E.D. Williamson Studies on the co-encapsulation, release and integrity of two subunit antigens: rV and rF1 from Yersinia Pestis J Pharm Pharmacol 51 1999 991 997
16. K. Inaba, M. Inaba, N. Romani, H. Aya, M. Deguchi, and S. Ikehara Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte-macrophage colony-stimulating factor J Exper Med 176 1992 1693 1702
17. M.B. Lutz, N. Kutsch, A.L.J. Ogilvie, S. Rössner, F. Koch, and Romani N An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow J Immunol Methods 223 1999 77 92
18. H.F. Sun, K.G.J. Pollock, and J.M. Brewer Analysis of the role of vaccine adjuvants in modulating dendritic cell activation and antigen presentation in vitro Vaccine 21 9/10 2003 849 855
19. C. Scheicher, M. Mehlig, H.P. Dienes, and K. Reske Uptake of microparticle-adsorbed protein antigen by bone marrow derived dendritic cells results in up-regulation of interleukin-1-alpha and interleukin-12 p40/p35 and triggers prolonged, efficient antigen presentation Eur J Immunol 25 6 1995 1566 1572
20. U. McKeever, S. Barman, T. Hao, P. Chambers, S. Song, and L. Lunsford Protective immune responses elicited in mice by immunisation with formulations of poly(lactide-co-glycolide) microparticles Vaccine 20 2002 1524 1531
21. R. Audran, K. Peter, J. Dannull, Y. Men, E. Scandella, and M. Groettrup Encapsulation of peptides in biodegradable microspheres prolongs their MHC-class I presentation by dendritic cells and macrophages in vitro Vaccine 21 2003 1250 1255
22. H.C. Flick-Smith, J.E. Eyles, R. Hebdon, E.L. Waters, R.J. Beedham, and T.J. Stagg Mucosal or parenteral administration of microsphere-associated Bacillus anthracis protective antigen protects against anthrax infection in mice Infect Immunity 70 4 2002 2022 2028